Parthenon Therapeutics - We are Hiring ! Revenue and Competitors
Estimated Revenue & Valuation
- Parthenon Therapeutics - We are Hiring !'s estimated annual revenue is currently $3.5M per year.
- Parthenon Therapeutics - We are Hiring !'s estimated revenue per employee is $77,500
Employee Data
- Parthenon Therapeutics - We are Hiring ! has 45 Employees.
- Parthenon Therapeutics - We are Hiring ! grew their employee count by 45% last year.
Parthenon Therapeutics - We are Hiring !'s People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP, PRTH-101 and Protein Sciences | Reveal Email/Phone |
2 | VP, Head Research | Reveal Email/Phone |
3 | Head Drug Discovery & Co-Founder | Reveal Email/Phone |
4 | VP Clinical Operations | Reveal Email/Phone |
5 | Senior Director, Tumor Microenvironment | Reveal Email/Phone |
6 | Associate Director Pharmacology | Reveal Email/Phone |
7 | Chief Scientific Officer | Reveal Email/Phone |
8 | Chief Medical Officer | Reveal Email/Phone |
9 | Principal Scientist, Cancer Biology | Reveal Email/Phone |
10 | Bioinformatics Co-op | Reveal Email/Phone |
Parthenon Therapeutics - We are Hiring ! Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Parthenon Therapeutics - We are Hiring !?
Parthenon Therapeutics is inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment (TME). The interplay between cancer cells and their surrounding microenvironment is relevant in drug development as many cancers use the TME to build barriers that shield immune system attack. One approach, PRTH-101, breaks these barriers to overcome recalcitrant cancers. Based on rigorous, groundbreaking research, we are designing a portfolio of drug candidates to treat the right patients at the right time.
keywords:N/A
N/A
Total Funding
45
Number of Employees
$3.5M
Revenue (est)
45%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $27M | 45 | -62% | $281.5M |
#2 | $7.6M | 45 | -6% | $128.2M |
#3 | $3.5M | 45 | 18% | N/A |
#4 | $12.7M | 45 | -18% | N/A |
#5 | $3.7M | 45 | 18% | N/A |